Precigen, Inc. (PGEN) — Stock Score Summary

Precigen, Inc. (PGEN) has a MoatMap StockRank of 17/100 based on Quality (15/100), Value (32/100), and Momentum (55/100) factor scores. The current signal is STRONG SELL. Precigen is a clinical-stage biopharmaceutical company developing gene and cell therapies. It is highly unprofitable, burns significant cash, and lacks the commercialized high-ROIC profile required by our investment philosophy.

Precigen, Inc. is a biotechnology company developing gene and cell therapies to address unmet needs in oncology, autoimmune disorders, and infectious diseases, utilizing its advanced genomic engineering platform. The company's competitive moat is based on its proprietary UltraCAR-T and AdenoVerse technologies designed for rapid, flexible, and cost-effective therapeutic development. It aims to be a leader in the next generation of precision medicines.

Key Financial Metrics

Price$3.71
Market Cap$1.6B
P/E (Forward)-17.55
Price/Book67.72
Return on Equity-1145.4%
Return on Invested Capital-208.8%
Debt/Equity485.55
Gross Margin-35.4%
Operating Margin-25.8%
Revenue Growth1633.9%
Free Cash Flow$-90M

Precigen, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Precigen, Inc.’s (PGEN) StockRank?
MoatMap’s StockRank for Precigen, Inc. (PGEN) is 17/100, with a Strong Sell signal. It is a composite of Quality (15), Value (32), and Momentum (55) factor ranks across MoatMap’s 19,000+ stock universe.
Does Precigen, Inc. have an economic moat?
Precigen, Inc. (PGEN) has a Quality factor score of 15/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Precigen, Inc. a buy, hold, or sell?
MoatMap’s current signal for Precigen, Inc. (PGEN) is Strong Sell, based on a StockRank of 17/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Precigen, Inc. in?
Precigen, Inc. (PGEN) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksPGEN deep dive reportAI ChampionsHow we score stocksSense-check another stock